Kevin Barnett has served as a strategic advisor to leading Life Sciences companies for nearly 20 years. His consulting expertise spans a broad range of areas including corporate strategy, portfolio and product strategy, and operational effectiveness.
Kevin is a Partner at Promidian — a rapidly-growing consulting firm that’s focused on assisting Life Sciences executives in addressing their most pressing business challenges. Prior to joining Promidian, Kevin was Partner and Managing Director at Leerink Swann, a Life Sciences focused investment bank and consulting firm. Prior to that Kevin was Sr. Vice President and Global Practice Area Lead at Campbell Alliance, a Life Sciences consultancy. He also held management consulting positions at Deloitte Consulting and Mattson Jack Group. Before his career in consulting Kevin worked in various commercial roles with The Upjohn Company.
Kevin has authored a number of articles and presented at myriad industry conferences on key strategic issues facing the pharmaceutical and biotechnology industries. He has been quoted and referenced in leading business publications and industry trade journals including BusinessWeek, The Pink Sheet, The RPM Report, Pharmaceutical Executive, MedAdNews, PharmaVOICE, and Managed Healthcare Executive.
Kevin holds a Bachelor of Science degree in Bioengineering from Purdue University and a Master of Business Administration degree from Indiana University’s Kelley School of Business.